Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2022 ∙ Wang, M. Wen, W. Zhou, M. Wang, C. Feng, Z. H.
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Pan, Y. Du, L. Gan, Q. Ma, W. Wang, M. Lu, Z. Luo, Y.
Meta-analysis of whether influenza vaccination attenuates symptom severity in vaccinated influenza patients
All age groups Influenza Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Singh, A. K. Jena, A. Mahajan, G. Mohindra, R. Suri, V. Sharma, V.
Meta-analysis: hepatitis B vaccination in inflammatory bowel disease
Adolescents Adults Hepatitis B Efficacy/effectiveness Safety Administration
Rating:
Critically low
2022 ∙ Skafle, I. Nordahl-Hansen, A. Quintana, D. S. Wynn, R. Gabarron, E.
Misinformation about Covid-19 Vaccines on Social Media: Rapid Review
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Kissi, J. Kusi Achampong, E. Kumasenu Mensah, N. Annobil, C. Naa Lamptey, J.
Moving towards Digitising COVID-19 Vaccination Certificate: A Systematic Review of Literature
All age groups COVID-19 Coverage
Rating:
Not applicable
2022 ∙ Molica, S. Giannarelli, D. Montserrat, E.
mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Pratama, N. R. Wafa, I. A. Budi, D. S. Putra, M. Wardhana, M. P. Wungu, C. D. K.
mRNA Covid-19 vaccines in pregnancy: A systematic review
Pregnant women COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Wang, Ying Liu, Yu
Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review
Americas United States of America All age groups Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Etemadifar, M. Nouri, H. Pitzalis, M. Idda, M. L. Salari, M. Baratian, M. Mahdavi, S. Abhari, A. P. Sedaghat, N.
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Nabizadeh, F. Ramezannezhad, E. Kazemzadeh, K. Khalili, E. Ghaffary, E. M. Mirmosayyeb, O.
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
Loading...